rnelson	10.2217/17460875.1.3.267	<http://dx.doi.org/10.2217/17460875.1.3.267>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.2217/17460875.1.3.267"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/john-m-miles-19wmiho5rbbg2"><j.3:name>John M Miles</j.3:name><j.3:familyName>M Miles</j.3:familyName><j.3:givenName>John</j.3:givenName></j.3:Person></j.0:creator><j.0:title>Use of orlistat in obese, dyslipidemic patients</j.0:title><owl:sameAs rdf:resource="info:doi/10.2217/17460875.1.3.267"/><j.1:volume>1</j.1:volume><j.0:identifier>10.2217/17460875.1.3.267</j.0:identifier><owl:sameAs rdf:resource="doi:10.2217/17460875.1.3.267"/><j.1:endingPage>273</j.1:endingPage><j.2:pageStart>267</j.2:pageStart><j.2:volume>1</j.2:volume><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1746-0875"><owl:sameAs>urn:issn:1746-0875</owl:sameAs><j.1:issn>1746-0883</j.1:issn><j.2:issn>1746-0883</j.2:issn><owl:sameAs>urn:issn:1746-0883</owl:sameAs><j.0:title>Future Lipidology</j.0:title><j.1:issn>1746-0875</j.1:issn><j.2:issn>1746-0875</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:publisher>Future Medicine Ltd</j.0:publisher><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2006-06</j.0:date><j.2:pageEnd>273</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/robert-h-nelson-19wmiho5rbbg2"><j.3:name>Robert H Nelson</j.3:name><j.3:familyName>H Nelson</j.3:familyName><j.3:givenName>Robert</j.3:givenName></j.3:Person></j.0:creator><j.1:doi>10.2217/17460875.1.3.267</j.1:doi><j.1:startingPage>267</j.1:startingPage><j.2:doi>10.2217/17460875.1.3.267</j.2:doi></rdf:Description></rdf:RDF>
